EUVIMEDEUVIMED entdecken
Crossref

Predictors of esophago-gastric varices and variceal bleeding in patients receiving atezolizumab/bevacizumab for unresectable hepatocellular carcinoma

S. Ascari, R. Chen, M. Iavarone, B. Stefanini, F. Marra, G. Cabibbo, C. Vivaldi, A. Palloni, C. Soldà, F.R. Ponziani, E. Valenzi, F. Ravaioli und 17 weitere

Digestive and Liver Disease · 2025-02 · 57 · S31

DOI: 10.1016/j.dld.2025.01.059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive and Liver Disease, 2025-02. Verfasst von S. Ascari und 28 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ascari, S., Chen, R., Iavarone, M., Stefanini, B., Marra, F., Cabibbo, G., Vivaldi, C., Palloni, A., Soldà, C., Ponziani, F., Valenzi, E., Ravaioli, F., Franceschini, E., Tosetti, G., Campani, C., Celsa, C., Masi, G., Brandi, G., Lonardi, S., …, & Tovoli, F. (2025). Predictors of esophago-gastric varices and variceal bleeding in patients receiving atezolizumab/bevacizumab for unresectable hepatocellular carcinoma. Digestive and Liver Disease, 57, S31. https://doi.org/10.1016/j.dld.2025.01.059

Vancouver

Ascari S, Chen R, Iavarone M, Stefanini B, Marra F, Cabibbo G, et al. Predictors of esophago-gastric varices and variceal bleeding in patients receiving atezolizumab/bevacizumab for unresectable hepatocellular carcinoma. Digestive and Liver Disease. 2025;57:S31. doi:10.1016/j.dld.2025.01.059

BibTeX
@article{Ascari2025,
  author = {Ascari, S. and Chen, R. and Iavarone, M. and Stefanini, B. and Marra, F. and Cabibbo, G. and Vivaldi, C. and Palloni, A. and Soldà, C. and Ponziani, F.R. and Valenzi, E. and Ravaioli, F. and Franceschini, E. and Tosetti, G. and Campani, C. and Celsa, C. and Masi, G. and Brandi, G. and Lonardi, S. and Stella, L. and Pressiani, T. and Lani, L. and Dalbeni, A. and Svegliati-Baroni, G. and Federico, P. and Ielasi, L. and Lorenzo, S. De and Piscaglia, F. and Tovoli, F.},
  title = {Predictors of esophago-gastric varices and variceal bleeding in patients receiving atezolizumab/bevacizumab for unresectable hepatocellular carcinoma},
  journal = {Digestive and Liver Disease},
  year = {2025},
  volume = {57},
  pages = {S31},
  doi = {10.1016/j.dld.2025.01.059}
}
Kostenlos starten →